Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 12Breast Neoplasms 12Pain 11Neoplasms 10Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 6Agnosia 6Colonic Neoplasms 5Neuralgia 4Keratosis, Actinic 4Cancer Pain 4Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Chronic Pain 3Thyroid Neoplasms 2Stomach Neoplasms 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

toripalimab 1pembrolizumab 1bicalutamide 1Lidocaine 1Imiquimod 1Fluorescein 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Paget Disease, Extramammary × Lidocaine × Clear all
NCT02385188 2020-01-02

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

University Medical Center Nijmegen

Phase 3 Completed
25 enrolled

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡